Banner

Archived ISPOR CONNECTIONS Issues 1996-2014


» Value & Outcomes Spotlight

Value & Outcomes Spotlight Logo

Value & Outcomes Spotlight (formerly ISPOR Connections) is ISPOR’s publication for news and ideas from the ISPOR membership. Value & Outcomes Spotlight provides enhanced content on health policy and methodological issues and independent contributions from the field, as well as the scientific program of ISPOR Annual Meetings/Congresses/Regional Conferences, plus ISPOR news from around the world.


Archived ISPOR CONNECTIONS 2014 ISSUES

PRESIDENT'S MESSAGE
Reflections from Amsterdam

METHODOLOGY
Considerations When Meta-Analyzing Diagnostic Test Sensitivity and Specificity When an Adequate Reference Standard Exists
In this article, Wolowacz et al. examine common issues related to the measurement of health state utility values for economic models in clinical trials, and introduce the work of the ISPOR Task Force which is developing best practice guidelines.

Electronic Clinical Outcomes Assessments (eCOAs).  How Long Do They Take to Complete and How Burdensome are they for Patients?
In this article, AbuDagga and colleagues use data from the 2007 National Home and Hospice Care Survey to describe a cultural competency training (CCT) provision scale and examine the role of organizational and leadership factors on the adoption of CCT.

HEALTH POLICY
The Value of Oncology Therapies and Emerging Access Hurdles: Germany, Canada, and the United States
This article from Lee et al. details an inquiry into recent value paradigm shifts and emerging market access and reimbursement hurdles in oncology in three key countries—Germany, Canada, and the US—and identifies what can be learned from the evolving landscape for developing access strategies and value propositions.

How (Not) To Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDs): Recommendations from the URD Evaluation Project
Michael Schlander and colleagues report on an expert consensus recommending that the evaluation of drugs for ultra-rare disorders (URDs) should insist on strong evidence of clinical benefits, whereas meaningful economic analysis may require an entirely new evaluation paradigm, capturing social value beyond the aggregation of individual health gains valued by individual preferences.

LETTER FROM THE EDITOR
Letter from the Editor
ISPOR IN ACTION

The International Society for Pharmacoeconomics and Outcomes Research New CEO and Executive Director–Nancy S. Berg

ISPOR 17th Annual European Congress–New Challenges, New Frontiers!

ISPOR 17th European Congress Photo Gallery

ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award Presentation and Recipient Remarks: Martin Buxton and Bengt Jönsson, PhD

ISPOR 20th International Meeting Call for Abstracts

ISPOR 5th Latin America Conference Call for Abstracts


STUDENT CORNER
Connection and Collaboration: Student Activities at the ISPOR 17th Annual European Congress
  ISPOR CONNECTIONS Vol.20 No. 6
Pdf format
PRESIDENT'S MESSAGE
Reflections from Amsterdam

OUTCOMES ASSESSMENT
Measuring Health-State Utility Values in Clinical Trials: Can We Do Better?
In this article, Wolowacz et al. examine common issues related to the measurement of health state utility values for economic models in clinical trials, and introduce the work of the ISPOR Task Force which is developing best practice guidelines.

Provision of Cultural Competency Training in the National Home and Hospice Care Survey: The Role of Organizational and Leadership Factors
AbuDagga and colleagues use data from the 2007 National Home and Hospice Care Survey to describe a cultural competency training (CCT) provision scale and examine the role of organizational and leadership factors on the adoption of CCT.

Enhancing Meta-Analysis by Considering the Correlation between Two Outcomes
Roïz et al. present the current knowledge and applications of bivariate meta-analysis, and investigate when it can add power to traditional univariate meta-analysis.

METHODOLOGY
Changing Cycle Lengths in State-Transition Models: Doing it the Right Way
Chhatwal et al. describe a method to correctly change cycle lengths in state-transition models.
LETTER FROM THE EDITOR
Seems Time to Talk about Ebola …

ISPOR IN ACTION
ISPOR 6th Asia-Pacific Conference Summary: A Return to China
ISPOR 6th Asia-Pacific Conference Photo Gallery
ISPOR 20th Annual International Meeting Call for Abstracts

STUDENT CORNER
Welcome Notes from the ISPOR Student Network Advisor
  ISPOR CONNECTIONS Vol.20 No. 5
Pdf format
INCOMING PRESIDENTIAL ADDRESS
The Challenge of Universal Health
POLICY ANALYSIS

Personalized Medicine and Whole Genome Sequencing in the Era of Big Data: Challenges and Opportunities?
In this article, a multi-disciplinary team of authors discuss the challenges and opportunities presented by the advent of "big data" in medicine, using widespread clinical adoption of whole genome sequencing as a case study.

ECONOMIC EVALUATION

Modeling Alchemy: The Impact of Unorthodox Trial Design on Health Technology Appraisal Strategy
In this article, Hatswell et al. discuss clinical studies with open-label, crossover, and uncontrolled designs, as well as the subsequent impact on economic modelling, and health technology assessment.

Nutrition Economics – An Introduction
In this article, Freijer et al. provides an overview of nutrition economics and the upcoming ISPOR Medical Nutrition Economics Special Interest Group that will develop recommendations on economic evaluations to describe and quantify the costs and effectiveness of nutrition interventions, as well as to assess the impact for individuals, the health care system, and society as a whole with disease-related malnutrition (DRM) as the initial focus.

LETTER FROM THE EDITOR
Seems Time to Talk about Ebola …

ISPOR IN ACTION
Board of Directors Newly Elected members Take Office as of July 1, 2014
ISPOR Marilyn Dix Smith Leadership Award Presentation and Recipient Remarks: Karen Rascati, PhD, RPh
Amsterdam: The Place to be for Novelty
ISPOR 17th Annual Congress Program
WEB CONNECTIONS
 
STUDENT CORNER
ISPOR Student Interest Survey 2013-2014
  ISPOR CONNECTIONS Vol.20 No. 4
Pdf format
PRESIDENT'S MESSAGE
Outgoing Presidential Address-In a Time of Transition, ISPOR Continues to Fire on All Cylinders
ECONOMIC EVALUATION

Risk Sharing for Medical Devices: Has the Time Come?
In this article, Garfield et al. examine the feasibility of risk sharing arrangements between U.S. hospitals and medical device manufacturers.

POLICY ANALYSIS

Detecting Data Errors and Managing Such Errors in Retrospective Research
In this article, Wade and Chapman examine a practical framework for screening and managing errors in retrospective database research.

OUTCOMES ASSESSMENT

A Systematic Review of Patient-Reported Outcomes Measures to Assess Satisfaction with Drug Therapy in Clinical Trials
In this article, Rüdell et al. examined the evidence of the characteristics and development of patient reported outcome instruments that measure treatment satisfaction in clinical trials.

LETTER FROM THE EDITOR

Some Emerging Trends on Big Health Data

ISPOR IN ACTION
Return to the Great White North-ISPOR 19th Annual International Meeting
ISPOR 19th Annual International Meeting Award Recipients
ISPOR 19th Annual International Meeting Photo Gallery
ISPOR Value in Health Paper of the Year Award 2014
Beijing, China: Time to Focus on the Patients' Voice
ISPOR 6th Asia-Pacific Conference Program
ISPOR 17th Annual Congress Call for Abstracts
WEB CONNECTIONS
STUDENT CORNER
ISPOR Student Network
  ISPOR CONNECTIONS Vol. 20 No. 3
Pdf format
PRESIDENT'S MESSAGE
The Ongoing Debate about the Merits of RCTs versus Observational Studies
ECONOMIC EVALUATION

Insight Into HTA Decision Making Behind the EU's Current Crop of Biosimilars
In this article, Shamika de Sliva examines the landscape of biosimilar reimbursement in Europe.

Financial Toxicity: A Growing Concern Among Cancer Patients in the United States
In this article, McDougall et al. examine the conceptual issues and current research on the financial toxicity of cancer and discuss strategies and policy initiatives to address the problem

POLICY ANALYSIS

Harnessing the Power of the Digital Patient in the Clinical Development Process
In this article, Coman and Spaeder examine how the growing voice of stakeholders, from patients to payers, is changing the path of drug development.

LETTER FROM THE EDITOR

Looking Forward to Montréal

ISPOR IN ACTION
Marilyn Dix Smith's ISPOR Legacy
ISPOR Board of Directors Report
ISPOR 19th Annual International Meeting Program
ISPOR 17th Annual European Congress Call for Abstracts
2014 ISPOR Board of Directors Election – Candidate Information
WEB CONNECTIONS
STUDENT CORNER
ISPOR Student Network SAS Tutorial Series
  ISPOR CONNECTIONS Vol. 20 No. 2
Pdf format
PRESIDENT'S MESSAGE
Health Care Expenditure Modeling with Observational Databases: How can Economic Theory Help?
ECONOMIC EVALUATION

When Collecting Patient Data Gets Electronic: The Upsurge Of Ehealth And The Importance Of Big Data To Shape Modern Health Care
In this article, in this article, Delbecque et al. discuss the promises and challenges of using electronic patient-reported outcomes (ePRO) and present a novel approach to exploiting real-world big data to enable precision medicine.

POLICY ANALYSIS

An Analysis on the Existence of an Official Positive List of Medical Devices in Europe, North America, Western Pacific and Western Asia
In this article, in this article, Seyhun and Erdol examine whether there is an official national positive list of medical devices in the selected countries of Europe, North America, Western Pacific and Western Asia which could be a reference and thus have an impact in the reimbursement decision making process of Social Security Institution of Turkey.

OUTCOMES ASSESSMENT

Social Media, Patients and Health Care: What’s the Story?
In this article, Abogunrin and Lombard explore the ever-increasing role for social media in health economics and outcomes research.

LETTER FROM THE EDITOR

We Analyzed Big Data Before Big Data Exisited

ISPOR IN ACTION
Think of It as Going to Europe, But Without the Jet Lag!
ISPOR 19th Annual International Meeting Program
ISPOR 6th Asia-Pacific Conference Call for Abstracts

2014 ISPOR Board of Directors Election – Candidate Information

STUDENT CORNER

ISPOR Student using Internships to Gain Real-World Research Experience

  ISPOR CONNECTIONS Vol.20 No. 1
Pdf format

Copyright © 2014 International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
All rights reserved under International and Pan-American Copyright Conventions.